Such an approach aligns with modern public health priorities, offering the potential to reduce colorectal cancer incidence while simultaneously addressing obesity, diabetes, and cardiovascular disease
Warnings - Zepbound may cause tumors in the thyroid, including thyroid cancer
Hematocrit should be checked at 36 months then annually, with testosterone dose reduction if levels exceed 54%, while testosterone levels should be monitored at 36 months after initiation or dose changes
The compound did not affect fasting glucose, insulin, HbA1c, IGF-1, cortisol, thyroid hormones, or liver enzymes (Thompson et al., 2004)
Mavromatis In addition to their known proven benefits in diabetes, cardiovascular disease [and] kidney disease, its possible they have additional oncologic benefits, Mavromatis told Healio
Reputable compounders will provide CoAs on request, and your provider should be able to obtain this documentation